Adalimumab-induced interstitial pneumonia in patients with inflammatory bowel disease.

Certain, M-C; Georges, M; Beltramo, G; Schenesse, D; Mouillot, P; Tankéré, P; Bonniaud, P

Certain, M-C; Georges, M; Beltramo, G; Schenesse, D; Mouillot, P; Tankéré, P; Bonniaud, P.

Afiliação

Certain MC; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France.
Georges M; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France; Inserm U1231, Faculty of Medicine and Pharmacy, Dijon France; University of Bourgogne-Franche Comté, Dijon, France.
Beltramo G; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France; Inserm U1231, Faculty of Medicine and Pharmacy, Dijon France; University of Bourgogne-Franche Comté, Dijon, France.
Schenesse D; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France.
Mouillot P; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France.
Tankéré P; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France.
Bonniaud P; Department of Pulmonary Medicine and Intensive Care Unit, Reference Center for Rare Lung Diseases, University Hospital, Bourgogne-Franche Comté, 21000 Dijon, France; Inserm U1231, Faculty of Medicine and Pharmacy, Dijon France; University of Bourgogne-Franche Comté, Dijon, France. Electronic address

Respir Med Res ; 78: 100790, 2020 Nov.

Article em En | MEDLINE | ID: mdl-33002817

Assuntos

Doenças Inflamatórias Intestinais; Doenças Pulmonares Intersticiais; Adalimumab/efeitos adversos; Humanos; Doenças Inflamatórias Intestinais/complicações; Doenças Inflamatórias Intestinais/tratamento farmacológico; Doenças Pulmonares Intersticiais/diagnóstico; Doenças Pulmonares Intersticiais/diagnóstico por imagem

Palavras-chave

Adalimumab; Anti-tumor necrosis factor; Inflammatory bowel disease; Interstitial lung disease; Pulmonary sarcoidosis-like

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doenças Pulmonares Intersticiais Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google